Visceral Obesity and Hemostatic Profile in Patients with Type 2 Diabetes: the Effect of Gender and Metabolic Compensation
Author(s) -
Elżbieta Kozek,
Barbara Katra,
Maciej T. Małecki,
Jacek Sieradzki
Publication year - 2004
Publication title -
the review of diabetic studies
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.701
H-Index - 41
eISSN - 1614-0575
pISSN - 1613-6071
DOI - 10.1900/rds.2004.1.122
Subject(s) - fibrinogen , medicine , endocrinology , abdominal obesity , plasminogen activator , fibrinolysis , obesity , type 2 diabetes , plasminogen activator inhibitor 1 , gastroenterology , diabetes mellitus , metabolic syndrome
Type 2 diabetes (T2DM) patients are characterized by a very high risk of cardiovascular diseases. Among the factors that are responsible for this phenomenon are abdominal obesity and hemostatic abnormalities.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom